Pfizer enters 2026 facing earnings pressure from COVID revenue collapse and acquisition-related dilution. Click here to read ...

How “Genocide” Is Being Emptied of Meaning By Grant Gochin The ghosts of my murdered family demand justice, and I refuse to ...

The biotech announced a secondary stock issue. It aims to sell $300 million worth of common shares. Just after market close on Monday, Dyne announced that it has launched an underwritten public ...

SoFi Technologies faces a strong $30 resistance, with valuation outpacing fundamentals and EPS forecasts declining since 2021. SOFI's $1.5 billion equity offering raises significant dilution concerns ...